Janni W - Search Results

1

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Morra A, Schreurs MAC, Andrulis IL, Anton-Culver H, Augustinsson A, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brauch H, Broeks A, Buys SS, Camp NJ, Castelao JE, Cessna MH, Chang-Claude J, Chung WK; NBCS Collaborators; Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Devilee P, Dörk T, Dunning AM, Dwek M, Easton DF, Eccles DM, Eriksson M, Evans DG, Fasching PA, Fehm TN, Figueroa JD, Flyger H, Gabrielson M, Gago-Dominguez M, García-Closas M, García-Sáenz JA, Genkinger J, Grassmann F, Gündert M, Hahnen E, Haiman CA, Hamann U, Harrington PA, Hartikainen JM, Hoppe R, Hopper JL, Houlston RS, Howell A; ABCTB Investigators; kConFab Investigators; Jakubowska A, Janni W, Jernström H, John EM, Johnson N, Jones ME, Kristensen VN, Kurian AW, Lambrechts D, Le Marchand L, Lindblom A, Lubiński J, Lux MP, Mannermaa A, Mavroudis D, Mulligan AM, Muranen TA, Nevanlinna H, Nevelsteen I, Neven P, Newman WG, Obi N, Offit K, Olshan AF, Park-Simon TW, Patel AV, Peterlongo P, Phillips KA, Plaseska-Karanfilska D, Polley EC, Presneau N, Pylkäs K, Rack B, Radice P, Rashid MU, Rhenius V, Robson M, Romero A, Saloustros E, Sawyer EJ, Schmutzler RK, Schuetze S, Scott C, Shah M, Smichk… See abstract for full author list ➔ Morra A, et al. Among authors: janni w. Cancer Med. 2023 Aug;12(15):16142-16162. doi: 10.1002/cam4.6272. Epub 2023 Jul 3. Cancer Med. 2023. PMID: 37401034 Free PMC article.

2

Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.

Janni W, Hepp F, Strobl B, Rack B, Rjosk D, Kentenich C, Schindlbeck C, Hantschmann P, Pantel K, Sommer H, Braun S. Janni W, et al. Cancer. 2003 Jan 15;97(2):405-11. doi: 10.1002/cncr.11066. Cancer. 2003. PMID: 12518364 Free article.

3

Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?

Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, Rammel G, Sommer H, Dimpfl T, Friese K. Rack B, et al. Among authors: janni w. Breast Cancer Res Treat. 2003 Nov;82(2):83-92. doi: 10.1023/B:BREA.0000003955.73738.9e. Breast Cancer Res Treat. 2003. PMID: 14692652

4

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.

Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K. Janni W, et al. Cancer. 2005 Mar 1;103(5):884-91. doi: 10.1002/cncr.20834. Cancer. 2005. PMID: 15666325 Free article.

5

Detection of micrometastatic disease in bone marrow: is it ready for prime time?

Janni W, Rack B, Lindemann K, Harbeck N. Janni W, et al. Oncologist. 2005 Aug;10(7):480-92. doi: 10.1634/theoncologist.10-7-480. Oncologist. 2005. PMID: 16079315 Free article. Review.

6

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.

Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E. Fehm T, et al. Among authors: janni w. Cancer. 2006 Sep 1;107(5):885-92. doi: 10.1002/cncr.22076. Cancer. 2006. PMID: 16874814 Free article.

7

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Riethdorf S, et al. Among authors: janni w. Clin Cancer Res. 2007 Feb 1;13(3):920-8. doi: 10.1158/1078-0432.CCR-06-1695. Clin Cancer Res. 2007. PMID: 17289886

8

Treatment of pregnancy-associated breast cancer.

Janni W, Hepp P, Nestle-Kraemling C, Salmen J, Rack B, Genss E, Schindlbeck C, Friese K. Janni W, et al. Expert Opin Pharmacother. 2009 Oct;10(14):2259-67. doi: 10.1517/14656560903168906. Expert Opin Pharmacother. 2009. PMID: 19663633 Review.

9

Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.

Rack B, Schindlbeck C, Jückstock J, Genss EM, Hepp P, Lorenz R, Tesch H, Schneeweiss A, Beckmann MW, Lichtenegger W, Sommer H, Friese K, Janni W; SUCCESS Study Group. Rack B, et al. Among authors: janni w. Anticancer Res. 2010 May;30(5):1837-41. Anticancer Res. 2010. PMID: 20592389 Clinical Trial.

10

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

Fehm T, Müller V, Aktas B, Janni W, Schneeweiss A, Stickeler E, Lattrich C, Löhberg CR, Solomayer E, Rack B, Riethdorf S, Klein C, Schindlbeck C, Brocker K, Kasimir-Bauer S, Wallwiener D, Pantel K. Fehm T, et al. Among authors: janni w. Breast Cancer Res Treat. 2010 Nov;124(2):403-12. doi: 10.1007/s10549-010-1163-x. Epub 2010 Sep 22. Breast Cancer Res Treat. 2010. PMID: 20859679 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

539 results

Search Page